As the EU considers establishing an Agency comparable to the U.S. Biomedical Advanced Research and Development Authority (BARDA), our colleagues outlines a set of recommendations during #A2MDialogues organised by the European Public Health Alliance (EPHA)

Will the EU be a wise investor in biomedical R&D or a passive donor? How can we guarantee a public return on public investment? Find out more by watching the recording.